Evaluation of the 755nm Alexandrite Laser for Skin Toning and Epidermal Pigmented Lesions in Asian Skin Types

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to assess treatment for facial skin toning and removal of epidermal pigmented lesions for Asian patients using the 755nm Alexandrite laser

Conditions
-----------------
Epidermal Pigmented Lesions, Skin Toning

Intervention / Treatment
-----------------
* Device: 755nm Alexandrite Laser


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Is a healthy male or female between 18 and 85 years old Has unwanted facial epidermal pigmented lesions or desires facial skin toning and wishes to undergo laser treatments. Is willing to consent to participate in the study. Is willing to comply with all requirements of the study including being photographed, following post treatment care and attending all treatment and follow up visits. Has Fitzpatrick skin types III to IV. Exclusion Criteria: The subject is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period. The subject is hypersensitive to light exposure OR takes photo sensitized medication. The subject has active or localized systemic infections The subject has a coagulation disorder, or is currently using anti-coagulation medication (including but not limited to heavy aspirin therapy {greater than 81 mg per day}). The subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study. The subject is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within 3 months prior to entering this study. The subject has used Accutane within 6 months prior to enrollment. The subject has the need to be exposed to artificial tanning devices or excessive sunlight during the trial. The subject has had prior treatment with parenteral gold therapy (gold sodium thiomalate). The subject has a history of keloids or hypertrophic scarring. The subject has evidence of compromised wound healing. The subject has a history of squamous cell carcinoma or melanoma The subject has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications. Allergic to topical lidocaine or topical steroids

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 85 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Device Feasibility
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: Participants are put into two groups (Pigmented Lesions/Skin Toning) to test prototype design and operating specifications. It is not a full clinical trial.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Alexandrite Laser for Skin Toning<br>755 nm Alexandrite Laser for Skin Toning | Device: 755nm Alexandrite Laser<br>* 755nm Alexandrite laser for treatment of epidermal pigmented lesions and skin toning in Asian skin types<br>|
| Experimental: Alexandrite Laser for Pigmented Lesions<br>755nm Alexandrite Laser for Epidermal Pigmented Lesions | Device: 755nm Alexandrite Laser<br>* 755nm Alexandrite laser for treatment of epidermal pigmented lesions and skin toning in Asian skin types<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Photographic Evaluation | 2D Photography to assess progress pre and post treatment | up to 4 months post last treatment |